BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Petagine L, Zariwala MG, Patel VB. Non-alcoholic fatty liver disease: Immunological mechanisms and current treatments. World J Gastroenterol 2023; 29(32): 4831-4850 [PMID: 37701135 DOI: 10.3748/wjg.v29.i32.4831]
URL: https://www.wjgnet.com/1948-5182/full/v29/i32/4831.htm
Number Citing Articles
1
Ziwei Guo, Qinjuan Wu, Pengfei Xie, Jiuchong Wang, Wenliang Lv. Immunomodulation in non-alcoholic fatty liver disease: exploring mechanisms and applicationsFrontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1336493
2
Ahmed M. Samy, Mohamed A. Kandeil, Dina Sabry, A.A. Abdel-Ghany, Mohamed O. Mahmoud. From NAFLD to NASH: Understanding the spectrum of non-alcoholic liver diseases and their consequencesHeliyon 2024; 10(9): e30387 doi: 10.1016/j.heliyon.2024.e30387
3
Lakshmi Arivazhagan, Sofie Delbare, Robin A. Wilson, Michaele B. Manigrasso, Boyan Zhou, Henry H. Ruiz, Kaamashri Mangar, Ryoko Higa, Emily Brown, Huilin Li, Michael J. Garabedian, Ravichandran Ramasamy, Kathryn J. Moore, Edward A. Fisher, Neil D. Theise, Ann Marie Schmidt. Sex differences in Murine MASH evoked by a Fructose-Palmitate-Cholesterol-Enriched DietJHEP Reports 2024; : 101222 doi: 10.1016/j.jhepr.2024.101222
4
U. Arshad, J.E.P. Santos. Graduate Student Literature Review: Exploring choline's important roles as a nutrient for transition dairy cowsJournal of Dairy Science 2024; 107(7): 4357 doi: 10.3168/jds.2023-24050
5
Asahiro Morishita, Kyoko Oura, Tomoko Tadokoro, Koji Fujita, Joji Tani, Hideki Kobara, Masafumi Ono, Takashi Himoto, Tsutomu Masaki. MicroRNAs and Nonalcoholic Steatohepatitis: A ReviewInternational Journal of Molecular Sciences 2023; 24(19): 14482 doi: 10.3390/ijms241914482
6
Isabella D. Cooper, Yvoni Kyriakidou, Kurtis Edwards, Lucy Petagine, Thomas N. Seyfried, Tomas Duraj, Adrian Soto-Mota, Andrew Scarborough, Sandra L. Jacome, Kenneth Brookler, Valentina Borgognoni, Vanusa Novaes, Rima Al-Faour, Bradley T. Elliott. Ketosis Suppression and Ageing (KetoSAge): The Effects of Suppressing Ketosis in Long Term Keto-Adapted Non-Athletic FemalesInternational Journal of Molecular Sciences 2023; 24(21): 15621 doi: 10.3390/ijms242115621
7
Grigorios Papadopoulos, Eirini Giannousi, Aikaterini P. Avdi, Rallia-Iliana Velliou, Polyxeni Nikolakopoulou, Antonios Chatzigeorgiou. Τ cell-mediated adaptive immunity in the transition from metabolic dysfunction-associated steatohepatitis to hepatocellular carcinomaFrontiers in Cell and Developmental Biology 2024; 12 doi: 10.3389/fcell.2024.1343806
8
Karolina Dereń, Joanna Kapusta-Duch, Teresa Leszczyńska, Barbara Borczak, Marta Kotuła. Pro-Health Potential of Selected Uncommon Oilseed PlantsApplied Sciences 2024; 14(19): 8843 doi: 10.3390/app14198843
9
Rhys W. Niedecker, Joseph A. Delaney, Margaret F. Doyle, Andrew D. Sparks, Colleen M. Sitlani, Petra Buzkova, Irfan Zeb, Russell P. Tracy, Bruce M. Psaty, Matthew J. Budoff, Nels C. Olson. Investigating peripheral blood monocyte and T-cell subsets as non-invasive biomarkers for asymptomatic hepatic steatosis: results from the Multi-Ethnic Study of AtherosclerosisFrontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1243526
10
Zhenguo Luo, Shu Yan, Yu Chao, Ming Shen. Unveiling the mitophagy puzzle in non-alcoholic fatty liver disease (NAFLD): Six hub genes for early diagnosis and immune modulatory rolesHeliyon 2024; 10(7): e28935 doi: 10.1016/j.heliyon.2024.e28935
11
Isabella D. Cooper, Yvoni Kyriakidou, Lucy Petagine, Kurtis Edwards, Adrian Soto-Mota, Kenneth Brookler, Bradley T. Elliott. Ketosis Suppression and Ageing (KetoSAge) Part 2: The Effect of Suppressing Ketosis on Biomarkers Associated with Ageing, HOMA-IR, Leptin, Osteocalcin, and GLP-1, in Healthy FemalesBiomedicines 2024; 12(7): 1553 doi: 10.3390/biomedicines12071553
12
ChongLi Xu, Fengyang Fu, Yuhan She, ChongBo Xu. NPC1L1 Plays a Novel Role in Nonalcoholic Fatty Liver DiseaseACS Omega 2023; 8(51): 48586 doi: 10.1021/acsomega.3c07337
13
Winston T. Stauffer, Asha Z. Goodman, Philippe A. Gallay. Cyclophilin inhibition as a strategy for the treatment of human diseaseFrontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1417945